1. Guariguata, L, Linnenkamp, U, Beagley, J, et al. Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract 2014; 103: 176–185.
Google Scholar | Crossref | Medline2. Cho, NH, Shaw, JE, Karuranga, S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 2018; 138: 271–281.
Google Scholar | Crossref | Medline3. HAPO Study Cooperative Research Group , Metzger, BE, Lowe, LP, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991–2002.
Google Scholar | Crossref | Medline4. Li, J, Song, C, Li, C, et al. Increased risk of cardiovascular disease in women with prior gestational diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract 2018; 140: 324–338.
Google Scholar | Crossref | Medline5. Bellamy, L, Casas, JP, Hingorani, AD, et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009; 373: 1773–1779.
Google Scholar | Crossref | Medline6. Clausen, TD, Mathiesen, ER, Hansen, T, et al. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care 2008; 31: 340–346.
Google Scholar | Crossref | Medline7. Plows, JF, Stanley, JL, Baker, PN, et al. The pathophysiology of gestational diabetes mellitus. Int J Mol Sci 2018; 19: 3342.
Google Scholar | Crossref8. Abell, SK, De Courten, B, Boyle, JA, et al. Inflammatory and other biomarkers: role in pathophysiology and prediction of gestational diabetes mellitus. Int J Mol Sci 2015; 16: 13442–13473.
Google Scholar | Crossref | Medline9. Tutunchi, H, Ostadrahimi, A, Hosseinzadeh-Attar, MJ, et al. A systematic review of the association of neuregulin 4, a brown fat-enriched secreted factor, with obesity and related metabolic disturbances. Obes Rev 2020; 21: e12952.
Google Scholar | Crossref | Medline10. Wang, GX, Zhao, XY, Meng, ZX, et al. The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis. Nat Med 2014; 20: 1436–1443.
Google Scholar | Crossref | Medline11. Ma, Y, Gao, M, Liu, D. Preventing high fat diet-induced obesity and improving insulin sensitivity through neuregulin 4 gene transfer. Sci Rep 2016; 6: 26242.
Google Scholar | Crossref | Medline12. Cai, CF, Lin, MZ, Xu, YF, et al. Association of circulating neuregulin 4 with metabolic syndrome in obese adults: a cross-sectional study. BMC Med 2016; 14: 165.
Google Scholar | Crossref | Medline13. Dai, YN, Zhu, JZ, Fang, ZY, et al. A case-control study: association between serum neuregulin 4 level and non-alcoholic fatty liver disease. Metabolism 2015; 64: 1667–1673.
Google Scholar | Crossref | Medline14. Kurek Eken, M, Sahin Ersoy, G, Yayla Abide, C, et al. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome. J Obstet Gynaecol 2019; 39: 975–980.
Google Scholar | Crossref | Medline15. Zhang, L, Fu, YM, Zhou, N, et al. Circulating neuregulin 4 concentrations in patients with newly diagnosed type 2 diabetes: a cross-sectional study. Endocrine 2017; 57: 535–538.
Google Scholar | Crossref | Medline16. Yan, PJ, Xu, Y, Wan, Q, et al. Plasma neuregulin 4 levels are associated with metabolic syndrome in patients newly diagnosed with type 2 diabetes mellitus. Dis Markers 2018; 2018: 6974191.
Google Scholar | Crossref | Medline17. Kurek Eken, M, Yayla Abide, C, Sahin Ersoy, G, et al. Clinical significance of neuregulin 4 (NRG4) in gestational diabetes mellitus. Gynecol Endocrinol 2018; 34: 605–608.
Google Scholar | Crossref | Medline18. Kralisch, S, Hoffmann, A, Kratzsch, J, et al. The brown-fat-secreted adipokine neuregulin 4 is decreased in gestational diabetes mellitus. Diabetes Metab 2018; 44: 150–154.
Google Scholar | Crossref | Medline19. Guma, A, Martinez-Redondo, V, Lopez-Soldado, I, et al. Emerging role of neuregulin as a modulator of muscle metabolism. Am J Physiol Endocrinol Metab 2010; 298: E742–E750.
Google Scholar | Crossref | Medline20. Britsch, S . The neuregulin-I/ErbB signaling system in development and disease. Adv Anat Embryol Cell Biol 2007; 190: 1–65.
Google Scholar | Medline21. Canto, C, Pich, S, Paz, JC, et al. Neuregulins increase mitochondrial oxidative capacity and insulin sensitivity in skeletal muscle cells. Diabetes 2007; 56: 2185–2193.
Google Scholar | Crossref | Medline22. Canto, C, Suarez, E, Lizcano, JM, et al. Neuregulin signaling on glucose transport in muscle cells. J Biol Chem 2004; 279: 12260–12268.
Google Scholar | Crossref | Medline23. Cote, GM, Miller, TA, Lebrasseur, NK, et al. Neuregulin-1alpha and beta isoform expression in cardiac microvascular endothelial cells and function in cardiac myocytes in vitro. Exp Cell Res 2005; 311: 135–146.
Google Scholar | Crossref | Medline24. Heim, P, Morandi, C, Brouwer, GR, et al. Neuregulin-1 triggers GLUT4 translocation and enhances glucose uptake independently of insulin receptor substrate and ErbB3 in neonatal rat cardiomyocytes. Biochim Biophys Acta Mol Cell Res 2020; 1867: 118562.
Google Scholar | Crossref | Medline25. Ennequin, G, Boisseau, N, Caillaud, K, et al. Neuregulin 1 improves glucose tolerance in db/db mice. PLoS ONE 2015; 10: e0130568.
Google Scholar | Crossref | Medline26. Ennequin, G, Caillaud, K, Chavanelle, V, et al. Neuregulin 1 treatment improves glucose tolerance in diabetic db/db mice, but not in healthy mice. Arch Physiol Biochem 2020; 126: 320–325.
Google Scholar | Crossref | Medline27. Arpaci, H . Circulating neuregulin-1 levels in polycystic ovary syndrome. J Obstet Gynaecol 2019; 39: 504–509.
Google Scholar | Crossref | Medline28. Matthews, DR, Hosker, JP, Rudenski, AS, et al. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.
Google Scholar | Crossref | Medline29. Chen, Z, Wang, G, Ma, S, et al. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders. Mol Metab 2017; 6: 863–872.
Google Scholar | Crossref | Medline30. Zeng, F, Wang, Y, Kloepfer, LA, et al. ErbB4 deletion predisposes to development of metabolic syndrome in mice. Am J Physiol Endocrinol Metab 2018; 315: E583–E593.
Google Scholar | Crossref | Medline31. Miller, TA, Icli, B, Cote, GM, et al. Palmitate alters neuregulin signaling and biology in cardiac myocytes. Biochem Biophys Res Commun 2009; 379: 32–37.
Google Scholar | Crossref | Medline32. Leddy, MA, Power, ML, Schulkin, J. The impact of maternal obesity on maternal and fetal health. Rev Obstet Gynecol 2008; 1: 170–178.
Google Scholar | Medline33. Tenenbaum-Gavish, K, Hod, M. Impact of maternal obesity on fetal health. Fetal Diagn Ther 2013; 34: 1–7.
Google Scholar | Crossref | Medline34. Chen, LL, Peng, MM, Zhang, JY, et al. Elevated circulating Neuregulin4 level in patients with diabetes. Diabetes Metab Res Rev 2017; 33: e2870.
Google Scholar | Crossref35. Hayes, NVL, Blackburn, E, Boyle, MM, et al. Expression of neuregulin 4 splice variants in normal human tissues and prostate cancer and their effects on cell motility. Endocr Relat Cancer 2011; 18: 39–49.
Google Scholar | Crossref | Medline36. Zhang, P, Kuang, H, He, YL, et al. NRG1-Fc improves metabolic health via dual hepatic and central action. JCI Insight 2018; 3: e98522.
Google Scholar | Crossref | Medline37. Ennequin, G, Boisseau, N, Caillaud, K, et al. Neuregulin 1 affects leptin levels, food intake and weight gain in normal-weight, but not obese, db/db mice. Diabetes Metab 2015; 41: 168–172.
Google Scholar | Crossref | Medline38. Pantham, P, Aye Powell, TL. Inflammation in maternal obesity and gestational diabetes mellitus. Placenta 2015; 36: 709–715.
Google Scholar | Crossref | Medline39. Yan, P, Xu, Y, Zhang, Z, et al. Decreased plasma neuregulin 4 levels are associated with peripheral neuropathy in Chinese patients with newly diagnosed type 2 diabetes: a cross-sectional study. Cytokine 2019; 113: 356–364.
Google Scholar | Crossref | Medline40. Shi, J, Xu, W, Zheng, R, et al. Neuregulin 4 attenuate tubulointerstitial fibrosis and advanced glycosylation end products accumulation in diabetic nephropathy rats via regulating TNF-R1 signaling. Am J Transl Res 2019; 11: 5501–5513.
Google Scholar | Medline41. Marballi, K, Quinones, MP, Jimenez, F, et al. In vivo and in vitro genetic evidence of involvement of neuregulin 1 in immune system dysregulation. J Mol Med 2010; 88: 1133–1141.
Google Scholar | Crossref | Medline